Deconstructing mitochondrial dysfunction in Alzheimer disease.

Area of Science:

• Neuroscience
• Cell Biology
• Pathology

Background:

• Mitochondrial damage is increasingly recognized as central to Alzheimer disease (AD) pathogenesis.
• This damage is associated with increased reactive oxygen species (ROS) production and disrupted mitochondrial dynamics.
• Mitochondrial dysfunction is linked to amyloid-beta, tau pathology, and presenilin-1 mutations in AD.

Purpose of the Study:

• To review the contribution of key factors to mitochondrial dysfunction in Alzheimer disease.
• To explore therapeutic strategies targeting mitochondria and autophagy in AD.
• To highlight the importance of human cellular models for studying mitochondrial function in AD.

Main Methods:

• Review of existing literature on mitochondrial damage, oxidative stress, and autophagy in Alzheimer disease.
• Discussion of therapeutic interventions, including mitochondrial-targeted antioxidants and autophagy modulation.
• Summary of novel protocols for generating human neuronal models via reprogramming and transdifferentiation.

Main Results:

• Mitochondrial damage is implicated as both a cause and consequence of AD pathology.
• Therapeutic potential exists for mitochondrial-targeted antioxidants and enhancing autophagy for damaged mitochondria clearance.
• Human cellular models are essential for advancing the understanding of mitochondrial roles in AD.

Conclusions:

• Mitochondrial dysfunction is a significant hallmark of Alzheimer disease, influenced by oxidative stress and impaired autophagy.
• Targeting mitochondria and autophagy presents promising therapeutic avenues for AD.
• Development of human neuronal models is critical for future research into AD pathogenesis and treatment.